Arcadia Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arcadia Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q2 2024.
  • Arcadia Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $1.98M.
  • Arcadia Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$9.7M, a 11.2% increase year-over-year.
  • Arcadia Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$13.9M, a 0.49% increase from 2022.
  • Arcadia Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$14M, a 60.6% increase from 2021.
  • Arcadia Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$35.5M, a 178% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$9.7M $1.98M +$3.43M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$13.1M -$3.06M +$803K +20.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$13.9M -$5.38M -$3.77M -234% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$10.2M -$3.24M +$749K +18.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$10.9M -$1.45M +$2.33M +61.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$13.3M -$3.87M +$756K +16.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$14M -$1.61M +$12.2M +88.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$26.2M -$3.99M +$4.72M +54.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$30.9M -$3.78M +$3.9M +50.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$34.8M -$4.62M +$703K +13.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$35.5M -$13.8M -$21.3M -285% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$14.3M -$8.71M -$1.13M -14.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$13.1M -$7.68M -$806K -11.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$12.3M -$5.33M +$464K +8.01% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$12.8M $7.47M +$11.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$24.2M -$7.58M -$1.39M -22.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$22.8M -$6.88M -$1.89M -38% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$21M -$5.79M -$1.57M -37.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$19.4M -$3.99M +$366K +8.41% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$19.7M -$6.19M -$2.09M -51.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$17.7M -$4.98M -$404K -8.83% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$17.2M -$4.22M -$379K -9.87% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$16.9M -$4.35M -$1.35M -45.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 -$15.5M -$4.1M -$484K -13.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$15M -$4.58M -$841K -22.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$14.2M -$3.84M +$124K +3.13% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$14.3M -$3M +$2.47M +45.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$16.8M -$3.62M +$312K +7.95% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$17.1M -$3.74M +$552K +12.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$17.7M -$3.96M +$970K +19.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$18.6M -$5.47M -$1.4M -34.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-20
Q3 2016 -$17.2M -$3.93M +$308K +7.27% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$17.5M -$4.29M -$742K -20.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$16.8M -$4.93M -$1.22M -32.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$15.6M -$4.07M -$2.44M -150% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-08
Q3 2015 -$13.1M -$4.24M +$1.71M +28.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$14.8M -$3.55M +$1.45M +29% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$16.3M -$3.71M -$1.13M -43.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$15.2M -$1.63M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-08
Q3 2014 -$5.94M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$5M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$2.58M Jan 1, 2014 Mar 31, 2014 10-Q 2015-06-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.